ALGS·01626L204·US·equity·Healthcare - Biotechnology-Activist
ALGS (ALIGOS THERAPEUTICS INC) is held by 24 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($3.1M), MARSHALL WACE, LLP ($2M), BANK OF AMERICA CORP /DE/ ($1.7M). Net institutional sentiment: Mixed.
See how ALGS's score breaks down across 4 SEC sources
Showing 1-20 of 30
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer